Routt, E. “Long Term Outcomes for Basal Cell Carcinoma Treated With Vismodegib Extended Alternate Day Dosing”. SKIN The Journal of Cutaneous Medicine, vol. 3, no. 2, Mar. 2019, pp. 150-1, doi:10.25251/skin.3.2.32.